July 2024 FDA Recall Timolol Maleate by Fdc Limited
D-0632-2024 - Defective container; yellow colored spike from cap lodged in the nozzle

This Class II drug recall was voluntarily initiated by Fdc Limited on July 18, 2024 for the product Timolol Maleate. The FDA reported the reason for recall as defective container; yellow colored spike from cap lodged in the nozzle. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0632-2024

Reason for Recall
Defective container; yellow colored spike from cap lodged in the nozzle
Initiated
07-18-2024
Reported
08-21-2024
Quantity
362,544 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the US
Timolol Maleate Ophthalmic Solution USP, 0.5%, Sterile, 5mL bottles, Rx only, Manufactured by: FDC Limited, Waluj, Aurangabad, Maharashtra, India, Distributed by: Rising Pharmaceuticals Inc, New Jersey, [NDC 64980-514-05].

Batch or Lot Expiration Information

Lot# Lot Number: 083J022, Expiration Date: September- 25; 083L046, Expiration date: November- 25; 083H009, Expiration date: July- 25